Method of treating dopaminergic and gaba-nergic disorders

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/12 (2006.01) A61K 31/00 (2006.01) A61K 31/47 (2006.01) A61K 31/472 (2006.01) A61K 31/496 (2006.01) A61K 31/553 (2006.01) A61K 31/7076 (2006.01) A61K 31/711 (2006.01) A61K 38/17 (2006.01) A61K 48/00 (2006.01) C07H 21/04 (2006.01) C07K 14/47 (2006.01) C12Q 1/68 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2297410

It is shown here that hedgehog proteins or mimicking agents possess novel activities beyond phenotype specification. Using cultures derived from the embryonic day 14.5 (E14.5) rat ventral mesencephalon, we show that hedgehog or mimicking agents are also trophic for dopaminergic neurons. Interestingly, hedgehog or mimicking agents not only promote dopaminergic neuron survival, but also promote the survival of midbrain GABA-immunoreactive (GABA-ir) neurons.

Selon cette invention, les protéines "en hérisson" ou des agents de mimétisme ont de nouvelles activités qui dépassent la spécification phénotypique. En utilisant les cultures dérivées du mésencéphale ventral d'un embryon du rat de 14,5 jours (E14,5), on a demontré que les protéines "en hérisson" sont également trophiques vis-à-vis des neurones dopaminergiques. Il est intéressant de noter que ces protéines "en hérisson" favorisent non seulement la survie des neurones dopaminergiques mais aussi celle des neurones immunoréactifs au GABA (GABA-ir) du mésencéphale.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Method of treating dopaminergic and gaba-nergic disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating dopaminergic and gaba-nergic disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating dopaminergic and gaba-nergic disorders will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1639983

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.